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Abstract 20 
Objective: To determine the effect of a model osteoarthritis (OA) consultation (MOAC) 21 
informed by NICE recommendations compared with usual care on recorded quality of care of 22 
clinical OA in general practice. 23 
Design: Two-arm cluster randomised controlled trial. 24 
Setting: Eight general practices in Cheshire, Shropshire, or Staffordshire UK. 25 
Participants: General practitioners and nurses with patients consulting with clinical OA.  26 
Intervention: Following six-month baseline period practices were randomised to 27 
intervention (n=4) or usual care (n=4). Intervention practices delivered MOAC (enhanced 28 
initial GP consultation, nurse-led clinic, OA guidebook) to patients aged ≥45 years consulting 29 
with clinical OA. An electronic (e-)template for consultations was used in all practices to 30 
record OA quality care indicators.  31 
Outcomes: Quality of OA care over six months recorded in the medical record.  32 
Results: 1851 patients consulted in baseline period (1015 intervention; 836 control); 1960 33 
consulted following randomisation (1118 intervention; 842 control). At baseline wide 34 
variations in quality of care were noted. Post-randomisation increases were found for written 35 
advice on OA (4% to 28%), exercise (4% to 22%) and weight loss (1% to 15%) in 36 
intervention practices but not controls (1% to 3%). Intervention practices were more likely to 37 
refer to physiotherapy (10% vs 2%, odds ratio 5.30; 95%CI 2.11, 13.34), and prescribe 38 
paracetamol (22% vs 14%, 1.74; 95%CI 1.27, 2.38).  39 
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Conclusions: The intervention did not improve all aspects of care but increased core NICE 40 
recommendations of written advice on OA, exercise and weight management. There remains 41 
a need to reduce variation and uniformly enhance improvement in recorded OA care.  42 
Trial registration number: ISRCTN06984617 43 
Keywords: Osteoarthritis, General practice, Implementation, Primary care, Guidelines 44 
 45 
  46 
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Introduction 47 
Osteoarthritis (OA) is a major cause of pain and disability worldwide1,2. Most patients with 48 
clinical OA are seen and managed in primary care, and the UK National Institute for Health 49 
and Care Excellence (NICE) has identified a set of core interventions which can be offered to 50 
all patients consulting with OA in primary care. Yet much primary care for OA patients in the 51 
UK does not adhere to NICE guidance, including the core items of education and information 52 
provision, and advice and referral for exercise and weight management1,3-6. Internationally, 53 
the situation is similar7,8 and a change in models of care for OA has been proposed9. 54 
A systematic review has previously identified some limited evidence to support primary care 55 
collaborative care models and multidisciplinary case management as complex interventions 56 
to improve OA care10. Strategies to improve quality of primary care for long-term conditions 57 
in the UK have included use of computerised templates and decision support systems11, 58 
health trainers12, promotion of self-management13, and educational intervention14. Although 59 
some risk factors for OA are addressed by the health trainer model (weight management, 60 
exercise/physical activity), there have been few successful attempts to enhance OA care in 61 
general practice. 62 
The MOSAICS (Managing OSteoArthritis In ConsultationS) study was a cluster randomised 63 
controlled trial to test a complex patient-focused intervention, namely a model OA 64 
consultation during which the core NICE OA recommendations are delivered. This was  65 
developed using the Whole Systems Informing Self-Management Engagement (WISE) 66 
model15 and incorporated an OA Guidebook developed with user involvement, an enhanced 67 
OA consultation, and access to a practice based nurse-led OA clinic.16,17 The MOSAICS 68 
study aimed to assess:  69 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
• the effectiveness of the intervention on the quality of primary care for patients aged ≥45 70 
years consulting with clinical OA. 71 
• the impact, feasibility and acceptability of the model OA consultation in primary care.  72 
We report here the practice-level results addressing the study question of whether the 73 
intervention (model OA consultation) increases the uptake of NICE OA recommendations by 74 
general practices taking part in MOSAICS, as measured by quality indicators of OA care in 75 
the practices’ electronic health records (EHR). A quality indicator was defined as “a 76 
measurable element of practice performance for which there is evidence or consensus that it 77 
can be used to assess the quality, and hence change in the quality, of care provided”18. We 78 
also report on adverse events. 79 
Methods 80 
Study Design 81 
MOSAICS was a mixed methods study with a two arm cluster randomised controlled trial 82 
conducted in eight general practices in Cheshire, Shropshire, or Staffordshire, UK. The 83 
protocol has been published17 and the patient-level self-reported outcomes for clinical 84 
effectiveness will be reported elsewhere.  85 
The MOSAICS study has two key parts: a population survey that took place between May 86 
2011 and April 2012 and a cluster randomised trial that was conducted from May 2012 to 87 
February 2014 by the Arthritis Research UK Primary Care Centre, Keele University, UK. 88 
The study was approved by the North West 1 Research Ethics Committee, Cheshire (REC 89 
reference: 10/H1017/76) and monitored by an Independent Trial Steering Committee and 90 
Data Monitoring Committee.  91 
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Cluster randomisation at the practice level was used to prevent contamination by clinicians as 92 
it was expected GPs would be unable to manage patients allocated to the control arm 93 
differently to those allocated to the intervention arm. It may also better develop a community 94 
of practice for OA care within a cluster. The evaluation of the intervention used anonymised 95 
medical records to allow the analysis of the management and care of a large number of 96 
patients without recruitment bias and the attrition and non-consent issues of self-reported 97 
patient evaluation. By using medical record information for measuring the outcomes, all 98 
eligible patients in the practices were included. 99 
Participants  100 
Practices which were members of the Central England Primary Care Research Network or a 101 
Keele Research Network Practice, and used the EMIS computerised system were approached 102 
sequentially until eight agreed to take part. Ten general practices were invited to participate. 103 
Reasons for non-participation were recent engagement with teaching medical students and 104 
involvement with other research19. 105 
All health care professionals (general practitioners and practice nurses) from the eight 106 
randomised practices and their respective practice populations aged ≥45 years consulting 107 
with clinical OA (diagnosed OA or recorded peripheral joint pain) formed the sampling 108 
frame for the cluster trial.  109 
During a six month baseline period prior to randomisation, all practices received a resource 110 
pack of written advice for patients, with examples of OA leaflets provided by Arthritis 111 
Research UK, Arthritis Care and NICE. Training of health care professionals in the trial 112 
intervention occurred after randomisation.  113 
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Patients eligible for inclusion were aged ≥45 years and had at least one consultation recorded 114 
as clinical OA defined as an OA diagnostic Read code or a code for joint pain (hand/wrist, 115 
hip, knee, foot/ankle) during the study period. In UK primary care, morbidities are generally 116 
entered using Read Codes, a hierarchical coding system structured into chapters. For 117 
example, codes under Chapter N represent ‘Musculoskeletal and Connective Tissue 118 
Diseases’. GPs may often enter symptom codes rather than diagnosis codes and using only 119 
OA diagnostic Read codes means patients presenting with OA symptoms will be missed20,21. 120 
Joint pain codes likely to represent OA had previously been determined by six academic 121 
general practitioners with an interest in musculoskeletal conditions22. The current analysis 122 
was performed on the anonymised electronic health record (EHR) data of all patients 123 
fulfilling the eligibility criteria.  124 
Randomisation  125 
Following the six month baseline period, practices were randomised into intervention (model 126 
OA consultation, four practices) or to continue with usual care (four practices). Practices 127 
were randomly allocated, stratified by practice list size, by administrative staff at the Keele 128 
Clinical Trials Unit who had no clinical involvement in the trial. The trial statisticians were 129 
kept blind to the allocation until after the analysis. 130 
Intervention 131 
The model OA consultation 132 
The development of the intervention has been published elsewhere17,23,24. Briefly, using the 133 
findings of two consensus exercises23,25 and theoretical models to guide self-management26  134 
and support patient behaviour change27,28, a model OA consultation was developed. This 135 
comprised an enhanced initial consultation with the GP and provision of a nurse-led OA 136 
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clinic, both supported by use of an OA Guidebook, and was delivered to patients aged ≥45 137 
years presenting with clinical OA (appendix 1). 138 
Training  139 
Training and educational packages were developed by drawing on Michie et al28,29. 140 
Intervention practices received practice updates on core NICE recommendations for OA 141 
(diagnosis; written information [the OA guidebook], exercise and physical activity, healthy 142 
eating, pain management). GPs received training on how to deliver the initial consultation for 143 
new or established OA patients during four sessions (2 hours x3, 1 hour x1) utilizing 144 
simulated patients in skills training sessions16. The procedure for referring to a practice nurse 145 
for a follow-up OA consultation was discussed. Practice nurses received four days of training 146 
on how to support and enable patients to self-manage OA, using a patient-centred approach, 147 
the OA guidebook, goal setting, pain management (analgesia and exercise) and the core 148 
NICE recommendations (information and advice, strengthening exercise and aerobic fitness 149 
training, and weight management)30.  150 
Control practices received no training, guidebook or OA nurse clinic, and continued usual 151 
care alongside the resource pack of written advice for patients given in the pre-randomisation 152 
baseline period.  153 
Outcomes 154 
The outcomes were the recorded achievement (achieved versus not achieved) of fourteen 155 
quality indicators of care for patients presenting with clinical OA during the six month period 156 
after randomisation and training. This was assessed through the use of quality indicators 157 
derived from a systematic review31 with additional measures derived from the NICE OA 158 
guidelines (Box 1)1. They cover four domains: assessment (pain, function, body mass index 159 
(BMI), X-ray use), core management (OA information, exercise advice, weight loss advice), 160 
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other non-pharmacological management (physiotherapy referral), and pharmacological 161 
management (paracetamol, topical non-steroidal anti-inflammatory drugs (NSAIDs), 162 
gastroprotection). For the core management indicators, indicator achievement was defined as 163 
the information being given verbally, written, or deemed by the clinician as not appropriate. 164 
However, we also assessed whether there had been increases in the level of written 165 
information and advice as this is the core NICE recommendation1.  166 
Recorded achievement of quality indicators was identified via two sources: information 167 
routinely entered in the EHR as part of standard care and that entered through an electronic 168 
template (“e-template”) developed  to allow clinicians to complete and capture information 169 
not routinely recorded (Box 1). The e-template was installed in all practices at the start of the 170 
six-month baseline period and was automatically triggered at any consultation with an entry 171 
of the same Read codes used to identify patients for the trial. Clinicians could choose to 172 
complete all, some, or none of the e-template. As previously reported, the e-template was 173 
found to be associated with an increased recording of weight and prescription of NICE-174 
recommended first-line analgesics (paracetamol, topical NSAIDS) in the baseline period but 175 
other recorded care remained stable32. 176 
Quality indicators could be achieved at the first consultation for clinical OA within the trial 177 
period or the following 120 days (to allow time for the patient to see the practice nurse). For 178 
indicators assessed through the routine record, they also had to be recorded within 14 days of 179 
a recorded consultation for clinical OA.  180 
The percentage of patients in the intervention practices with a recorded practice nurse 181 
consultation (as directed in the model OA consultation) were identified from medical records 182 
as a measure of treatment fidelity.  183 
Adverse events 184 
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Adverse events that may be related to the content of the model OA consultation and quality 185 
of care indicators were selected based on the NICE 2008 OA guidelines1 and  186 
recommendations of the Trial Steering Committee, and identified in the EHR from date of 187 
first OA consultation during the trial period up the last point of record download (31/8/2013). 188 
Sample size 189 
Sample size for the trial was based on the clinical effectiveness component17. A priori, based 190 
on a 10% annual consultation prevalence for clinical OA in those aged ≥4522, and a 191 
population base of 30,000 adults aged ≥45 years across the eight general practices, we 192 
estimated there would be 3,000 patients consulting annually for clinical OA.  193 
Statistical analysis 194 
The analysis compared the intervention and control practices on recorded achievement of the 195 
individual quality indicators of care in patients consulting with clinical OA during the trial 196 
period (six months after randomisation and training). We determined practice-specific 197 
baseline levels of recorded quality indicator achievement. Baseline was taken as the first six 198 
months the e-template was introduced in the practices (prior to randomisation and training) 199 
and was based on patients with a recorded OA or joint pain code during that period.  During 200 
the six month trial period, we identified the initial clinician recorded as seen by each patient 201 
for clinical OA in that period.   202 
Multilevel logistic regression models (patients nested within initial clinician seen) were used 203 
to determine differences between intervention and control practices during the trial period in 204 
the achievement of each quality indicator. The models were adjusted for age, gender, whether 205 
the initial consultation was recorded as diagnosed OA or given a joint pain code, and baseline 206 
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level of quality indicator achievement of the patient’s practice. Results are presented as odds 207 
ratios (OR) with 95% CI. 208 
Sensitivity analyses restricted the analysis to: (i) patients with at least one recorded entry on 209 
the e-template, (ii) new consulters (defined as first clinical OA consultation since 210 
introduction of the e-template and with at least 365 days since any clinical OA consultation), 211 
(iii) patients with a recorded diagnosis of OA.   212 
To assess the likely effect of treatment fidelity, we descriptively compared recorded 213 
achievement of quality indicators, in the intervention practices only, between patients with a 214 
record of attendance at a practice nurse clinic and those without.  215 
Differences in adverse events were analysed using chi-squared tests or Fisher’s Exact Test as 216 
appropriate. Stata/MP 13.1, MLwiN v2.29 and the Stata command ‘runmlwin’ were used for 217 
the analyses33,34. 218 
Results  219 
Mean registered populations for the practices were 10240.5 (intervention) and 6983.3 220 
(control). There were 1118 patients recorded with clinical OA during the six month trial 221 
period in the intervention practices, and 842 patients in the control practices (figure 1). Mean 222 
age of patients was 66.2 years (SD 12.34, intervention) and 66.5 (SD 11.93, control). 59% 223 
were female in the intervention practices, 61% in the control practices. The e-template fired 224 
for 1061 (95%) of the 1118 patients in the intervention practices and 757 (90%) of the 842 225 
patients in the control practices. The reason for the template failing to fire for the remaining 226 
patients is unknown. 227 
Figure 1 here 228 
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41% (baseline) and 45% (trial period) of patients in the intervention practices received an OA 229 
diagnosis rather than a joint pain code compared to 23% and 29% in the control practices, 230 
respectively. During the trial period, there were 63 clinicians who first saw a patient in the 231 
intervention practices (seeing a median of 10 patients; IQR 2, 29) and 50 clinicians in the 232 
control practices (median 11 patients; IQR 2, 26).  233 
Recorded achievement of quality indicators  234 
There was wide variation in recorded achievement of the quality indicators during the 235 
baseline pre-randomisation period, measured through the e-template, between clinicians and 236 
between practices. For example, as previously reported32, in clinicians seeing more than the 237 
median number of clinical OA patients, a quarter failed to achieve any e-template measured 238 
indicator for more than half of their patients but another quarter achieved at least one 239 
indicator for more than 88% of their patients. This variation was reflected in wide baseline 240 
differences between the trial arms and there was a fall in recorded achievement of e-template 241 
measured indicators between baseline and trial period for both intervention and control 242 
practices, although this was not apparent in patients who had at least one entry on the e-243 
template.  244 
There were no statistically significant differences between intervention and control practices 245 
in the recorded achievement of the assessment quality indicators although X-ray requests 246 
reduced in the intervention arm (25% to 15%) but increased in the control practices (3% to 247 
6%, OR 0.45; 95% CI 0.12, 1.72, table 1). There were also no statistically significant 248 
differences in the general indicators of core management. However, a record of the health 249 
care professional supplying written information on OA increased in the intervention practices 250 
from 4% of patients in the baseline period to 28% in the trial period and remained stable in 251 
the control practices (1 to 2%, OR 23.60, 95% CI 7.39, 75.40, table 2). Written exercise 252 
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advice and written weight loss advice in those overweight  also increased significantly in the 253 
intervention practices in comparison to the control practices.  254 
Physiotherapy referral remained stable in intervention practices (9% baseline, 10% trial 255 
period) and decreased slightly in control practices (4% to 2%; comparison in trial period 256 
between intervention practices and control practices: OR 5.30; 95% CI 2.11, 13.34). 257 
Prescribing of paracetamol increased from the baseline period in the intervention arm (16% 258 
to 22%) and decreased in the control arm (19% to 14%, OR 1.74; 95% CI 1.27, 2.38). 259 
Tables 1 & 2 here. 260 
Restricting the analysis of indicators measured through the e-template to patients with at least 261 
one entry suggested a higher rate in the intervention practices of consideration of paracetamol 262 
use (OR 2.01; 95% CI 0.91, 4.41) and advice to exercise (OR 1.88; 95% CI 0.93, 3.79), albeit 263 
not statistically significant (appendix table 1). As in the main analysis, there were decreases 264 
from baseline in recorded achievement of the indicators measured through the e-template in 265 
new consulters and just those with an OA diagnosis. Restricting the analyses of indicators 266 
recorded through the routine records to new consulters for clinical OA did not change the 267 
findings from the main analysis (appendix table 2).  In those with an OA diagnostic code 268 
only, patients in the intervention practices were additionally more likely to have their weight 269 
recorded (OR 3.07; 95% CI 1.37, 6.90) than those in the control practices (appendix table 3). 270 
There were larger increases in the intervention arm in those with an OA diagnosis for the core 271 
written aspects of management (written information 6% to 42%; written exercise advice 6% 272 
to 33%; written weight loss advice 3% to 24%) than seen in the main analysis (table 2).   273 
220 (21%) of patients with clinical OA in the intervention practices had a record of attending 274 
a practice nurse clinic. There was a higher percentage of patients with an OA diagnosis in 275 
those attending the nurse clinic than in those who did not attend the nurse clinic (68% versus 276 
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40%). Except for physiotherapy referral and X-ray request, those who saw a practice nurse 277 
had higher levels of recorded achievement in indicators measured either through the routine 278 
records or through the e-template. In particular, 89% of those consulting a practice nurse 279 
received written information compared to 24% of those who did not (in those who had at 280 
least one entry on the e-template). There were also higher levels of written exercise advice 281 
(80% versus 13%) and written weight loss advice (44% versus 10%) (table 3). 282 
Table 3 here 283 
Adverse events 284 
An adverse event was recorded in 13% of patients in the intervention arm and 11% in the 285 
control arm (table 4). Differences between arms were small and the one significant difference 286 
between arms was for heart failure (1.5% intervention arm versus 0.5% control arm). Of note, 287 
only two of the 17 patients with heart failure in the intervention arm had been prescribed 288 
either paracetamol or an oral NSAID for clinical OA during the trial period. 289 
Table 4 here 290 
Discussion 291 
A model OA consultation, informed by NICE recommendations and incorporating an 292 
enhanced initial GP consultation, nurse-led OA clinic, and OA Guidebook, compared with 293 
usual care, substantially increased uptake of core written non-pharmacological 294 
recommendations, though there remained scope for further improvement. The model OA 295 
consultation produced higher levels of prescribing of simple analgesia (paracetamol) and 296 
physiotherapy referral. There was a reduction in referral for X-ray in the intervention 297 
practices (although not statistically significant) and little evidence that the model OA 298 
consultation was associated with a higher number of adverse events. However, wide variation 299 
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in recorded management was identified and evidence of improvement in recorded 300 
achievement was not consistent across all indicators. 301 
A novelty of our study was use of anonymised practice-level data to study the effect of the 302 
intervention on all patients consulting with OA or joint pain. Uptake of recommended NICE 303 
management of OA were measured using previously identified quality indicators of OA 304 
care31 captured via an e-template, and routinely recorded information. To enhance the uptake 305 
of NICE OA recommendations we used theory-derived interventions, clinical champions, 306 
outreach visits, theory-informed training, funded practice nurse clinics, supply of high quality 307 
patient information, and a model OA consultation to deliver evidence-based 308 
recommendations. The extent to which each of these approaches contributed independently 309 
cannot be determined. The model OA consultation had a strong theoretical underpinning 310 
using the WISE model to define self-management and patient information and the Theoretical 311 
Domains Framework to develop training to deliver the consultation13,16.  312 
Our earlier work had shown that the template was a feasible way for GPs to record care, and 313 
that the introduction of the template alone had positive effects on quality care such as 314 
prescribing32. Introducing the model OA consultation had no discernible additional influence 315 
on the level of recording of items on the e-template beyond baseline. However, despite the 316 
limited number of practices in the trial and wide variation across practices, there was an 317 
important and statistically significant improvement in a key component of NICE guidance, 318 
namely the provision of written information about OA and written advice about exercise and 319 
weight control, in the intervention compared with control practices.  320 
A strength was introduction of the e-template and familiarisation six months prior to 321 
randomisation to capture for the first time information on recommended indicators of quality 322 
of care not routinely captured in the EHR. The e-template alone increased the use of topical 323 
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NSAIDS32 which reduced the likelihood of detecting further increases as a result of the model 324 
OA consultation. Use of paracetamol also showed a trend in favour of increased use in the 325 
baseline period, however there was a further statistically significant increase in use following 326 
implementation of the model OA consultation. The template failed to fire for a small group of 327 
patients. Whilst the reason for this is unknown, it is unlikely to have introduced any bias.  328 
The baseline level of achievement in various domains pre-randomisation was already high 329 
when compared with other published estimates of recorded quality of care4,5,7,8. Levels of 330 
achievement of OA quality indicators as measured through the e-template fell generally from 331 
baseline levels, possibly due to initiative fatigue in use of the template. On completion of the 332 
research however seven of the eight practices chose to continue with the e-template. We also, 333 
in a sensitivity analysis, restricted analysis to patients with at least one e-template entry to try 334 
and overcome some of the influence of the fall in overall recording.  However, the higher 335 
baseline levels of quality achievement compared to previous estimates, general fall in 336 
recording, and baseline variation between practices and health care professionals limited 337 
investigation of the potential effect of the intervention. There was an imbalance in the 338 
number of patients between arms due to the inclusion of one much larger practice. We 339 
included patients with consultations coded as knee, hip, hand/wrist and foot/ankle pain, as 340 
non-specific pain at these sites in older adults is most likely to be underlying OA. Recorded 341 
joint pain in other sites which may present as OA (shoulder and elbow) were not included, 342 
however these sites made up just 2% of OA diagnosed consultations during the trial period. 343 
In the analysis, we clustered patients within clinicians rather than practices. We performed a 344 
sensitivity analysis (data not shown) with practice as an extra level in the multilevel models. 345 
This showed the majority of variation was at clinician level and did not change the findings. 346 
The extent to which the recorded quality of care reflects the actual delivery of care is not 347 
known. Given quality of care is necessarily measured across several indicators, the testing of 348 
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multiple comparisons could not be avoided and increased the possibility that identified 349 
differences between arms were due to chance.  350 
Only 21% of patients in the intervention arm attended the practice nurse clinics. Referral by 351 
the GP and attendance by the patient were optional. Patients with an OA diagnosis were more 352 
likely to attend and had increased uptake of core treatments suggesting that making a formal 353 
OA diagnosis was linked to management. It is possible those given an OA diagnosis have 354 
more severe pain or functional limitation although other work suggests that known risk 355 
factors (older age, obesity) are more strongly linked to OA diagnosis than severity20. 356 
The provision of OA guidebooks in the intervention arm was captured by the increased 357 
uptake of written information on OA. This is an important outcome for the trial given the 358 
recent NICE Quality Standards for OA which highlights the importance of providing written 359 
information about OA and its management35. Access to weight loss advice and support is 360 
recommended in the NICE guidance and is regarded as a care quality indicator31. The 361 
increased use of written weight loss advice is another strength of the intervention. Previous 362 
studies have shown reliance by GPs on pharmacological management of OA3, so the increase 363 
in these non-pharmacological core interventions is encouraging. Further work is required to 364 
understand the extent to which provision of written information and advice affects patient 365 
outcomes. X-ray use declined in the intervention arm which is in line with NICE 366 
recommendations. 367 
There was an increased incidence of heart failure in the intervention arm. As only two of the 368 
17 patients with heart failure had been prescribed paracetamol or oral NSAIDs, it seems 369 
unlikely that this is due to a pharmacological effect, and it seems clinically implausible that 370 
the noted statistically significant difference is caused by the intervention.  371 
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In our novel practice-level analysis of anonymised data from all consulters with OA and joint 372 
pain, we have shown that a model OA consultation intervention which provides additional 373 
resources for a primary care-based OA service, notably a patient guidebook and practice 374 
nurse referral clinics, did not lead to improvements on all indicators of quality of OA care. 375 
However there was improved achievement of NICE guidance targets for written information 376 
and advice, and some small but additional beneficial effects on prescribing and referrals. 377 
Patient and public involvement (PPI) 378 
The Arthritis Research UK Primary Care Centre at Keele University is committed to taking 379 
an explicit and systematic approach to involving patients and the public in research. For this 380 
trial, a Research Users Group worked in collaboration with researchers on a wide range of 381 
tasks including: development and design of the OA guidebook24, developing training for GPs 382 
and practice nurses, grant co-applicant and Steering Committee Membership. 383 
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Box 1 – Quality indicators of primary care of osteoarthritis 
Domain Quality indicator Indicator 
sourcea 
Data source Evidence of achievement Change signalling 
care improvedb 
Assessment Pain assessed Review e-template Recorded level of painc Increase 
 Function assessed Review e-template Recorded level of functionc Increase 
 BMI measurement/weight 
record 
Review e-template & 
routine EHR 
Recorded BMI or weight Increase 
 X-ray requested Guideline Routine EHR Recorded X-ray of knee, hip, hand, or 
foot 
Decrease 
Core 
interventions 
OA information  Review e-template Recorded as verbal or written; or not 
appropriated 
Increase 
      Written OA information  Guideline e-template Recorded as written Increase 
 Exercise advice Review e-template Recorded as verbal or written; or not 
necessary or not appropriated 
Increase 
        Written exercise advice Guideline e-template Recorded as written Increase 
 Weight loss advicee  Review e-template Recorded as verbal or written; or not 
appropriated 
Increase 
 Written weight loss advicee Guideline e-template Recorded as written Increase 
Non- 
Pharmacological 
 interventions 
Consideration of 
physiotherapy referral 
Guideline e-template Recorded  as offered; or not necessary 
or not appropriated 
Increase 
Physiotherapy referral made Guideline Routine EHR Recorded referral to physiotherapy Increase 
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Pharmacological 
interventions 
Consideration of 
paracetamol use 
Review e-template Recorded as tried, offered, or declined 
full dose; or not appropriatef 
Increase 
Paracetamol prescribed Review Routine EHR Recorded prescription Increase 
 Consideration of topical 
NSAID use 
Guideline e-template Recorded as tried, offered or declined 
full dose; or not appropriatef 
Increase 
 Topical NSAID prescribed Guideline Routine EHR Recorded prescription Increase 
 Gastroprotection (PPI use 
with oral NSAIDs) 
Review Routine EHR Recorded prescription (if oral NSAID 
prescribed) 
Increase 
a
 Systematic review31 or NICE guideline1, indicators taken from routine record had to be within 14 days of a clinical OA consultation; b 
compared to control group; c none, mild, moderate, severe; d Not this time or no entry indicates non-achievement; e in those with  recorded BMI ≥ 
25 in previous 3 years; f Unknown or no entry indicates non-achievement. NSAID = non-steroidal anti-inflammatory drug; PPI = proton pump 
inhibitor. Clinicians were asked to record “not appropriate” when they considered a patient not eligible for a process of care.  
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Table 1 – Comparison between intervention and control arms in recorded quality indicator achievement  
  Baseline period Trial period   
 
Domain 
 Intervention 
n
a
 (%) 
Control 
n
a
 (%) 
Intervention 
n
a
 (%) 
Control 
n
a
 (%) 
 
ORb (95% CI) 
 
ICCc 
 No. of consultersd 1015 / 981 836 / 749 1118 / 1061 842 / 757   
Assessment Pain assessment 707 (72) 390 (52)   617 (58) 318 (42) 1.35 (0.58, 3.14) 0.36 
 Function assessment 691 (70) 384 (51)   611 (58) 309 (41) 1.15 (0.49, 2.71) 0.35 
 Weight record 278 (27) 154 (18)   309 (28) 144 (17) 1.36 (0.80, 2.33) 0.20 
 X-ray requested 250 (25)   22 (3)   163 (15)   47 (6) 0.45 (0.12, 1.72) 0.22 
Core management Information given 578 (59) 274 (37)   554 (52) 268 (35) 1.34 (0.61, 2.96) 0.34 
 Exercise advice 582 (59) 285 (38)   526 (50) 246 (32) 1.53 (0.75, 3.13) 0.28 
 Weight loss advicee 325 (53) 159 (34)   341 (49) 136 (31) 1.24 (0.61, 2.52) 0.28 
Non-pharmacological 
management 
Physiotherapy referral considered 426 (43) 192 (26)   348 (33) 173 (23) 1.45 (0.61, 3.40) 0.29 
Physiotherapy referral made   90 (9)   35 (4)   111 (10)   19 (2) 5.30 (2.11, 13.34) 0.20 
Pharmacological 
management 
Paracetamol considered 625 (64) 349 (47)   554 (52) 284 (38) 1.42 (0.71, 2.85) 0.29 
Paracetamol prescribed 164 (16) 155 (19)   241 (22) 117 (14) 1.74 (1.27, 2.38) 0.03 
 Topical NSAID considered 540 (55) 295 (39)   501 (47) 275 (36) 0.97 (0.48, 1.95) 0.28 
 Topical NSAID prescribed 267 (26) 194 (23)   327 (29) 186 (22) 1.21 (0.83, 1.76) 0.09 
 PPI prescribedf   63 (35)   27 (23)     69 (39)   50 (36) 0.92 (0.43, 1.98) 0.14 
a
 number of patients with record of achievement of indicator; b adjusted for age, gender, coded OA or joint pain, practice level of achievement in 
baseline period and accounting for clustering by clinician, reference is control group; c estimated intraclass correlation coefficient based on 
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adjusted model d number consulting for clinical OA in trial period and hence with routine record information / number for whom e-template 
fired; e In those recorded as overweight: baseline period intervention n = 615, control n = 470; trial period intervention n = 698, control n = 439. f 
on date of NSAID prescription in those prescribed oral NSAIDs: baseline period intervention n = 181, control n = 119; trial period intervention n 
= 176, control n = 137. NSAID = non-steroidal anti-inflammatory drug; PPI = proton pump inhibitor  
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Table 2 – Recorded achievement of quality indicators based on core NICE written recommendations by trial arm 
 Baseline period Trial period  
 Intervention Control Intervention Control  
 n (%) n (%) n (%) n (%) ORa (95% CI) 
All consulters firing e-template     
No. of consulters 981 749 1061 757  
Written information   36 (4)     6 (0.8)   296 (28)   12 (2) 23.60 (7.39, 75.40) 
Written exercise advice   38 (4)     8 (1)   232 (22)     7 (0.9) 21.49 (6.62, 69.72) 
Written weight loss adviceb     7 (1)     1 (0.2)   104 (15)     2 (0.5) 27.94 (3.56, 219.17) 
Coded with osteoarthritis diagnosis     
No. of consulters 410 178 483 218  
Written information   23 (6)     2 (1) 201 (42)     7 (3) 26.92 (6.33, 114.51) 
Written exercise advice   24 (6)     2 (1) 158 (33)     2 (0.9) 40.49 (5.64, 290.56) 
Written weight loss advicec     7 (3)     1 (0.9)   79 (24)     1 (0.8) d 
a  adjusted for age, gender, coded OA or joint pain, practice level of achievement in baseline period and accounting for clustering by clinician, 
reference is control group, b In those recorded as overweight: baseline period intervention n = 615, control n = 470; trial period intervention n =  
698, control n = 439, c In those recorded as overweight: baseline period intervention n = 272, control n = 114; trial period intervention n =  335, 
control n = 132; d model failed to converge 
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Table 3 - Recorded quality indicator achievement in those attending nurse clinics and those 
who did not during trial period – intervention arm only (4 practices) 
  Did not attend nurse clinic Attended nurse clinic 
  All 
n
a
 (%) 
≥1 e-template 
entry na (%) 
 
n
a
 (%) 
 No. of consultersb 840 416 220 
Assessment Pain assessment 398 (47) 398 (96) 218 (99) 
 Function assessment 392 (47) 392 (94) 218 (99) 
 Weight record 136 (16) N/A 168 (76) 
 X-ray requested 118 (14) N/A   36 (16) 
Core management Information given 338 (40) 338 (81) 215 (98) 
 Written information 100 (12) 100 (24) 195 (89) 
 Exercise advice 309 (37) 309 (74) 216 (98) 
 Written exercise advice   55 (7)   55 (13) 177 (80) 
 Weight loss advicec 193 (37) 193 (69) 147 (87) 
 Written weight loss advicec   29 (5)   29 (10)   75 (44) 
Non-pharmacological 
management 
Physiotherapy referral considered 215 (26) 215 (52) 132 (60) 
Physiotherapy referral made   91 (11) N/A   18 (8) 
Pharmacological 
management 
Paracetamol considered 352 (42) 352 (85) 201 (91) 
Paracetamol prescribed 160 (19) N/A   76 (35) 
 Topical NSAID considered 316 (38) 316 (76) 184 (84) 
 Topical NSAID prescribed 219 (26) N/A   94 (43) 
 PPId  prescribed   54 (38) N/A   14 (45) 
a
 Number (%) of patients with record of achievement of indicator, b 1 patient excluded as 
recorded nurse clinic was before start of analysis period; c In those recorded as overweight: 
not attended nurse clinic n=528, not attended nurse clinic but at least 1 e-template entry 
n=279, attended nurse clinic n=169. d In those prescribed NSAID, not attended nurse clinic 
n=142, attended nurse clinic=32. NSAID = non-steroidal anti-inflammatory drug. PPI = 
proton pump inhibitor. N/A = not applicable as quality achievement assessed using routine 
records 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
31 
 
Table 4 - Comparison between intervention and control arms on adverse events recorded 
from first consultation for OA or joint pain in trial period to 31st August 2013  
  Intervention Control p-valuea 
No. of consulters  1118 842  
No. of days of follow-up  Median (IQR) 416 (360, 460) 408 (355, 451)  
Death n (%)       1 (0.1)     1 (0.1) 0.68 
Heart failure n (%)     17 (1.5)     4 (0.5) 0.03e 
 New heart failureb n (%)       9 (0.8)     0 (0) 0.006e 
Gastrointestinal  n (%)       9 (0.8)     9 (1.1) 0.54 
Renal impairmentb n (%)     19 (1.7)   11 (1.3) 0.48 
Liver impairment / failure n (%)       0 (0)     0 (0) - 
Hypersensitivityc n (%)       1 (0.1)     2 (0.2) 0.40 
Asthma flareb n (%)     19 (1.7)   20 (2.4) 0.29 
Renal failured n (%)       2 (0.2)     0 (0) 0.33 
Myocardial infarction n (%)       2 (0.2)     5 (0.6) 0.13 
Stroke n (%)     14 (1.3)     5 (0.6) 0.14 
 New strokeb n (%)       8 (0.7)     2 (0.2) 0.12 
Fall n (%)     65 (5.8)   39 (4.6) 0.25 
Infection n (%)       6 (0.5)     1 (0.1) 0.12 
Deep vein thrombosis n (%)       0 (0)     0 (0) - 
Leg amputation n (%)       0 (0)     1 (0.1) 0.43 
Septic arthritis n (%)       0 (0)     0 (0) - 
Any adverse event n (%)   146 (13.1)   96 (11.4) 0.27 
a
 Chi-squared Test or Fisher’s Exact Test as appropriate; b New cases only, no record in 2 
years prior to index date; c includes angioedema and new cases of wheeze (no record in 2 
years prior to index date); d acute renal failure or chronic renal failure with no record of renal 
failure in 2 years prior to index date; e p < 0.05. Index date = date of first consultation for OA 
or joint pain in trial period 
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Figure 1 – Flowchart of practices and patients included in study 
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